U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H27NO
Molecular Weight 309.446
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LEVOMETHADONE

SMILES

CCC(=O)C(C[C@@]([H])(C)N(C)C)(c1ccccc1)c2ccccc2

InChI

InChIKey=USSIQXCVUWKGNF-QGZVFWFLSA-N
InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3/t17-/m1/s1

HIDE SMILES / InChI

Molecular Formula C21H27NO
Molecular Weight 309.446
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Sources: Helmut Buschmann (20 December 2002). Analgesics: From Chemistry and Pharmacology to Clinical Application. Wiley-VCH. p. 196. ISBN 978-3-527-30403-5. | F.. Macdonald (1997). Dictionary of Pharmacological Agents. CRC Press. p. 1294. ISBN 978-0-412-46630-4.
Curator's Comment:: see METHADONE

levomethadone, or R-(−)-methadone, is the active enantiomer of methadone; having approximately 50x the potency of the S-(+)-enantiomer as well as greater μ-opioid receptor selectivity.

CNS Activity

Curator's Comment:: http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/006134s040s041lbl.pdf

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
PubMed

PubMed

TitleDatePubMed
Standard binding and functional assays related to medications development division testing for potential cocaine and opiate narcotic treatment medications.
1998 Mar
Involvement of CYP3A4, CYP2C8, and CYP2D6 in the metabolism of (R)- and (S)-methadone in vitro.
2003 Jun
In silico prediction of pregnane X receptor activators by machine learning approaches.
2007 Jan
[Methadone and levomethadone - dosage and side effects].
2014 Mar
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment:: see METHADONE
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Curator's Comment:: see METHADONE
Unknown
Substance Class Chemical
Created
by admin
on Sat Jun 26 02:10:45 UTC 2021
Edited
by admin
on Sat Jun 26 02:10:45 UTC 2021
Record UNII
6Y75Z4E8NS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LEVOMETHADONE
INN   WHO-DD  
INN  
Official Name English
L-POLAMIVET
Common Name English
(6R)-6-(DIMETHYLAMINO)-4,4-DIPHENYL-3-HEPTANONE
Systematic Name English
D-(-)-METHADONE
Common Name English
(R)-METHADONE
Common Name English
R-(-)-METHADONE
Common Name English
(6R)-METHADONE
Common Name English
HEPTANONE, 6-(DIMETHYLAMINO)-4,4-DIPHENYL-, L-
Common Name English
(-)-METHADONE
Common Name English
LEVOTHYL
Brand Name English
(-)-(R)-6-(DIMETHYLAMINO)-4,4-DIPHENYL-3-HEPTANONE
Systematic Name English
3-HEPTANONE, 6-(DIMETHYLAMINO)-4,4-DIPHENYL-, (R)-
Systematic Name English
3-HEPTANONE, 6-(DIMETHYLAMINO)-4,4-DIPHENYL-, (6R)-
Systematic Name English
L-METHADONE
Common Name English
LEVOMETHADONE [WHO-DD]
Common Name English
POLAMIVET
Brand Name English
LEVOMETHADONE [INN]
Common Name English
Classification Tree Code System Code
WHO-ATC N07BC05
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
WHO-VATC QN07BC05
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
Code System Code Type Description
CAS
3861-94-7
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
SUPERSEDED
CAS
52310-03-9
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
SUPERSEDED
WIKIPEDIA
Levomethadone
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY
NCI_THESAURUS
C166969
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY
DRUG CENTRAL
4586
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY
EVMPD
SUB08477MIG
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY
PUBCHEM
22267
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY
RXCUI
236913
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY RxNorm
DRUG BANK
DB13515
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY
CAS
125-58-6
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY
ChEMBL
CHEMBL159659
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY
INN
5002
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY
FDA UNII
6Y75Z4E8NS
Created by admin on Sat Jun 26 02:10:45 UTC 2021 , Edited by admin on Sat Jun 26 02:10:45 UTC 2021
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
RACEMATE -> ACTIVE ENANTIOMER
approximately 50x the potency of the S-(+)-enantiomer as well as greater ?-opioid receptor selectivity
TRANSPORTER -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY